Improving Standard Therapies

Dr. Brad Nelson (2003 and 2004 Research Grants)

Dr. Brad Nelson’s research hopes to improve popular prostate cancer treatments like hormone therapy and radiation. In March 2007, he published a study that showed for the first time that, in addition to fighting cancer themselves, these therapies also stimulate the body’s own immune system to fight tumours.

Dr. Nelson identified 21 specific antigens that are released by prostate tumours and attacked by the immune system. He is now using these antigens to develop a drug that can improve the immune-friendly effects of radiation and hormone therapy. Ultimately, this drug – which would be given to men before treatment - could be a cost effective way of making therapy more effective and help men live longer.

Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive